



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Monday,
                        11 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    HEALTH AND FAMILY WELFARE






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

1110






                                    ANSWERED ON: 
                                

18.09.2020






Faulty COVID-19 Test Kits




Hibi Eden













                                                    Su Thirunavukkarasar
                                                












                        Will the Minister of





HEALTH AND FAMILY WELFARE


                        be pleased to state:-















                                                    Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:(a) whether the Government has imported huge quantity of COVID-19 antibody testing kits from China, if so, the details thereof;(b) the sequence of incidents which led the Government to withdraw the faulty COVID-19 antibody test kits from China and the grounds on which the import orders from China were cancelled;(c) whether there exist any complaints against massive profiteering and over-pricing in kits imported from China, if so, the details thereof;(d) whether the Government has taken any action or proposes to take any action against the persons involved in this serious lapse, if so, the details thereof; and(e) the steps taken by the Government to ensure availability of genuine testing kits to combat the disease?






ANSWER




                                                        ANSWERTHE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE(SHRI ASHWINI KUMAR CHOUBEY)(a)  ICMR placed purchase orders to Indian firms which were cancelled subsequently without any payment to any Chinese company. ICMR has not imported huge quantities of antibody test kits from China. (b)  Antibody kits of M/s Aark pharmaceutical (Woldfo) and M/s Gene2me (Livzon) were sent to field. When complaints were received from states of Rajasthan, Punjab, Karnataka regarding non-performance of the Antibody test kit in the field, and based upon the said feedback from the field, those purchase orders were canceled without any payment. Simultaneously, the licenses of these companies were also cancelled by Drug Controller General.(c)  ICMR has informed that they have not received any such complaint. However, a public grievance was received primarily describing a commercial dispute amongst different distributors of the kits supplied by Woldfo company, China. ICMR is not a party to said dispute amongst different distributers of a commercial entity. As there was no payment made by ICMR to any supplier, there was no further action to be taken by ICMR.(d)  Seventeen (17) importers were issued licenses in Form MD-15 between 26.03.2020 and 22.04.2020 for import of Antibody Rapid Diagnostic Kits from China under Medical Devices Rules,2017 subject to various conditions.ICMR reported that the above said Test Kits do not meet the specification in the field and issued order on 26.04.2020 cancelling the Purchase Orders.Pursuant to above information from ICMR, the importers were issued directions on 28.04.2020 to stop import of the said diagnostic kits as well as they were asked to show cause as to why action will not be taken to suspend or cancel their licenses.Subsequently, on 29.04.2020, after verification of the responses, as received, the importers were directed that no batches of the said Diagnostic kits should be imported for sale/ stock/ distribution or be sold or offered for sale and entire batches imported and supplied, should be recalled from the market including hospitals and accordingly, their import licenses were made infructuous and cancelled with immediate effect.(e)    Detailed requirements & conditions of the manufacturing/import license required to be complied by the licensee are prescribed in the MDR 2017.In addition to above, following steps have been taken to ensure availability of quality COVID-19 In-vitro Diagnostic Kits and reagents combat the disease in the country.ICMR in co-ordination with CDSCO has issued Guidelines for Validation and batch testing of COVID-19 diagnostic kits & for validation centres. Acceptance criteria for COVID-19 diagnostic kits & regents has been fixed by the ICMR Experts group for testing product and quality at the ICMR designated labs to ensure the quality of the product for recommendation to use in the country for testing patient samples.
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113192227







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







